www.tevapharma.es Open in urlscan Pro
45.60.34.221 Public Scan

Go To Rescan
Add Verdict Report

Submitted URL:
http://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml...
Effective URL:
https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml...
Submission: On June 18 via api (June 18th 2020, 4:51:35 am UTC) from US

Summary HTTP 28 Redirects Links 8 Behaviour Indicators

Summary

This website contacted 6 IPs in 3 countries across 5 domains to perform 28 HTTP transactions. The main IP is 45.60.34.221, located in United States and belongs to INCAPSULA, US. The main domain is www.tevapharma.es.
TLS certificate: Issued by GlobalSign CloudSSL CA - SHA256 - G3 on May 18th 2020. Valid for: a year.

This is the only time www.tevapharma.es was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

	IP Address	AS Autonomous System
1 24	45.60.34.221 45.60.34.221	19551 (INCAPSULA) (INCAPSULA)
1	2a00:1450:400... 2a00:1450:4001:825::2008	15169 (GOOGLE) (GOOGLE)
1	2606:2800:233... 2606:2800:233:1cb7:261b:1f9c:2074:3c	15133 (EDGECAST) (EDGECAST)
2	2a00:1450:400... 2a00:1450:4001:809::200e	15169 (GOOGLE) (GOOGLE)
1	13.69.65.22 13.69.65.22	8075 (MICROSOFT...) (MICROSOFT-CORP-MSN-AS-BLOCK)
28	6

24 45.60.34.221 (United States) 1 redirects

ASN19551 (INCAPSULA, US)

www.tevapharma.es	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:825::2008 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.googletagmanager.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:2800:233:1cb7:261b:1f9c:2074:3c (United States)

ASN15133 (EDGECAST, US)

az416426.vo.msecnd.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a00:1450:4001:809::200e (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.google-analytics.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 13.69.65.22 (Amsterdam, Netherlands)

ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US)

dc.services.visualstudio.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

	Apex Domain Subdomains	Transfer
24	tevapharma.es 1 redirects www.tevapharma.es	653 KB
2	google-analytics.com www.google-analytics.com	19 KB
1	visualstudio.com dc.services.visualstudio.com	519 B
1	msecnd.net az416426.vo.msecnd.net	22 KB
1	googletagmanager.com www.googletagmanager.com	37 KB
28	5

	Domain	Requested by
24	www.tevapharma.es	1 redirects www.tevapharma.es
2	www.google-analytics.com	www.googletagmanager.com www.tevapharma.es
1	dc.services.visualstudio.com	az416426.vo.msecnd.net
1	az416426.vo.msecnd.net	www.tevapharma.es
1	www.googletagmanager.com	www.tevapharma.es
28	5

This site contains links to these domains. Also see Links.

Domain
www.tevapharm.com
tevafarmacia.es
careers.teva
www.facebook.com
www.linkedin.com
twitter.com
www.youtube.com

Subject Issuer	Validity	Valid
incapsula.com GlobalSign CloudSSL CA - SHA256 - G3	`2020-05-18` - `2021-04-25`	a year	crt.sh
*.google-analytics.com GTS CA 1O1	`2020-05-26` - `2020-08-18`	3 months	crt.sh
sni1e6ffgl.wpc.edgecastcdn.net DigiCert SHA2 Secure Server CA	`2020-04-16` - `2022-04-21`	2 years	crt.sh
in.applicationinsights.azure.com Microsoft IT TLS CA 4	`2020-04-30` - `2022-04-30`	2 years	crt.sh

This page contains 1 frames:

Primary Page: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Frame ID: 2C1FBBC6162D09D1AD91F3143F49203A
Requests: 29 HTTP requests in this frame

Screenshot
Live screenshot

Full Image

Page URL History Show full URLs

http://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-... HTTP 301
https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-... Page URL

Detected technologies

Windows Server (Operating Systems) Expand

Overall confidence: 100%
Detected patterns

headers server /^(?:Microsoft-)?IIS(?:\/([\d.]+))?/i

IIS (Web Servers) Expand

Overall confidence: 100%
Detected patterns

headers server /^(?:Microsoft-)?IIS(?:\/([\d.]+))?/i

Google Analytics (Analytics) Expand

Overall confidence: 100%
Detected patterns

script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i

Google Tag Manager (Tag Managers) Expand

Overall confidence: 100%
Detected patterns

html //i

Page Statistics

28
Requests

100 %
HTTPS

60 %
IPv6

5
Domains

5
Subdomains

6
IPs

3
Countries

732 kB
Transfer

1916 kB
Size

11
Cookies

8 Outgoing links

These are links going to different origins than the main page.

URL: https://www.tevapharm.com/teva_worldwide/europe/
Title: Teva en el mundo

Search URL Search Domain Scan URL

URL: https://tevafarmacia.es/
Title: Teva farmacia

Search URL Search Domain Scan URL

URL: https://tevafarmacia.es/productos-genericos/a-z/a
Title: Línea OTC

Search URL Search Domain Scan URL

URL: https://careers.teva/?locale=es_ES
Title: Carreras

Search URL Search Domain Scan URL

URL: https://www.facebook.com/TevaPharmaEs
Title:

Search URL Search Domain Scan URL

URL: https://www.linkedin.com/organization-guest/company/teva-pharmaceuticals/?challengeId=AQGyr7ELBUy6ggAAAW0aJ4oISNTfnyNctz9zMAR2ni1szzjOYXzvuHRqOzCjT7mr8Lk21v1hbvF0KFCJ1i7EoQPuiyhRwvAJjg&submissionId=557cf5c4-5504-c315-c6de-cf63cec0e878
Title:

Search URL Search Domain Scan URL

URL: https://twitter.com/teva_es
Title:

Search URL Search Domain Scan URL

URL: https://www.youtube.com/user/TevaPharmaES
Title:

Search URL Search Domain Scan URL

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

http://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple HTTP 301
https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

28 HTTP transactions
1 data transactions

Method
Protocol Status Resource
Path Size
x-fer Time
Latency Type
MIME-Type IP
Location

GET
H2

404

Primary Request 309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple Show response
www.tevapharma.es/sala-de-prensa/notas-de-prensa/
Redirect Chain

http://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-escl...
https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esc...

39 KB
7 KB

651ms
611ms

Document
text/html

45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to

Full URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: Microsoft-IIS/10.0 / ASP.NET ARR/3.0
Resource Hash: 98d8e417b92060ec0b7e68a0e7867dc3d102078502c53fe0bfa5cf5cc4babff3

Request headers

:method: GET
:authority: www.tevapharma.es
:scheme: https
:path: /sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
pragma: no-cache
cache-control: no-cache
upgrade-insecure-requests: 1
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site: none
sec-fetch-mode: navigate
sec-fetch-user: ?1
sec-fetch-dest: document
accept-encoding: gzip, deflate, br
accept-language: en-US
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status: 404
cache-control: private
content-type: text/html; charset=utf-8
server: Microsoft-IIS/10.0
set-cookie: ASP.NET_SessionId=ptwdkpnttav2ezesnmabxbsw; path=/; HttpOnly; SameSite=Lax ARRAffinity=223242edffad9634629293fff1625d9fabbc117a1d9986a90aa14acc0ef3b705;Path=/;HttpOnly;Domain=www.tevapharma.es visid_incap_2161282=FQMdc4PASB21A8qA74Pi28Ly6l4AAAAAQUIPAAAAAADT1xxG2VJLH5eqoWUwuNRn; expires=Thu, 17 Jun 2021 06:49:11 GMT; HttpOnly; path=/; Domain=.tevapharma.es incap_ses_86_2161282=KtXES4HlUHr6b8zlx4gxAcPy6l4AAAAAw0tZ+ecXrFByWtBuj2+ywQ==; path=/; Domain=.tevapharma.es
x-aspnetmvc-version: 5.2
x-aspnet-version: 4.0.30319
request-context: appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
access-control-expose-headers: Request-Context
x-powered-by: ASP.NET ARR/3.0
date: Thu, 18 Jun 2020 04:51:15 GMT
x-cdn: Incapsula
content-encoding: gzip
x-iinfo: 6-11833682-11833683 NNYN CT(85 177 0) RT(1592455874783 0) q(0 0 3 0) r(6 6) U11

Redirect headers

Location: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Content-Length: 0
Connection: close

GET
H2 200 css
www.tevapharma.es/sala-de-prensa/notas-de-prensa/DependencyHandler.axd/e60934c81b33a244aaf066e442a45709/1/ 384 KB
46 KB 137ms
136ms Stylesheet
text/css 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to

Full URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/DependencyHandler.axd/e60934c81b33a244aaf066e442a45709/1/css
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash: 72898b978a56f0a24c0d9209b572e4a7cf87b69ac6890b9b882b8f79f5e6419d

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:15 GMT
content-encoding: gzip
x-cdn: Incapsula
x-aspnet-version: 4.0.30319
x-powered-by: ASP.NET, ARR/3.0
status: 200
x-iinfo: 6-11833744-11833683 PNNN RT(1592455875487 0) q(0 0 0 -1) r(2 2) U18
content-length: 46922
request-context: appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified: Thu, 18 Jun 2020 04:51:15 GMT
server: Microsoft-IIS/10.0
etag: "3be2707764d4078a0c30ac32d8ac52d1"
vary: Accept-Encoding
content-type: text/css
access-control-expose-headers: Request-Context
cache-control: public, must-revalidate, proxy-revalidate, max-age=864000, s-maxage=864000
expires: Sun, 28 Jun 2020 04:51:15 GMT

GET
H2 200 afro-american-curls-cafe-316x316.jpg
www.tevapharma.es/globalassets/scs-branded-images/small-teaser-images/ 29 KB
29 KB 412ms
411ms Image
image/jpeg 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.tevapharma.es/globalassets/scs-branded-images/small-teaser-images/afro-american-curls-cafe-316x316.jpg
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: /
Resource Hash: ea4e0d8ed97a6e82485ac81a9cc3c5643cf95e76294d9f74a373569d51b91ceb

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:15 GMT
last-modified: Mon, 22 Jul 2019 11:04:39 GMT
x-cdn: Incapsula
etag: "1D5407D416C3D80"
content-type: image/jpeg
status: 200
x-iinfo: 6-11833745-11833436 2VNN RT(1592455875490 0) q(0 0 0 -1) r(4 4) U18
cache-control: max-age=86400, public
content-length: 29564
expires: Fri, 19 Jun 2020 04:51:15 GMT

GET
H2 200 pills_shelves_teaser_316x316.jpg
www.tevapharma.es/globalassets/scs-branded-images/small-teaser-images/ 21 KB
21 KB 429ms
427ms Image
image/jpeg 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.tevapharma.es/globalassets/scs-branded-images/small-teaser-images/pills_shelves_teaser_316x316.jpg
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: /
Resource Hash: 49dff39efabb14fbfc8627cdb57ac74ef3d1ec9ab7f5cdfd0a6a56d56e6e7b67

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:15 GMT
last-modified: Tue, 07 Aug 2018 06:06:47 GMT
x-cdn: Incapsula
etag: "1D42E14D2B6B580"
content-type: image/jpeg
status: 200
x-iinfo: 6-11833758-11833753 2VNN RT(1592455875655 0) q(0 0 0 -1) r(4 4) U18
cache-control: max-age=86401, public
content-length: 21269
expires: Fri, 19 Jun 2020 04:51:16 GMT

GET
H2 200 man_child_mobile_316x316.jpg
www.tevapharma.es/globalassets/scs-branded-images/small-teaser-images/ 16 KB
16 KB 1178ms
1176ms Image
image/jpeg 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.tevapharma.es/globalassets/scs-branded-images/small-teaser-images/man_child_mobile_316x316.jpg
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: /
Resource Hash: b1aacf5ee9c8a84c439a304d839dbe17e343c53de6c44d719554541f90ede67e

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:16 GMT
last-modified: Wed, 12 Dec 2018 15:34:50 GMT
x-cdn: Incapsula
etag: "1D49230383A0900"
content-type: image/jpeg
status: 200
x-iinfo: 6-11833759-11831858 2VNN RT(1592455875657 0) q(0 0 0 -1) r(12 12) U18
cache-control: max-age=86400, public
content-length: 16605
expires: Fri, 19 Jun 2020 04:51:16 GMT

GET
H2 200 navigation-image.jpg
www.tevapharma.es/globalassets/spain-branded-images/humanize-health-images/ 28 KB
28 KB 404ms
401ms Image
image/jpeg 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.tevapharma.es/globalassets/spain-branded-images/humanize-health-images/navigation-image.jpg
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: /
Resource Hash: f0873e78f822286e1a5c34f5c8241607e5b65e7e6c36c5682378f9b96af32f20

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:15 GMT
last-modified: Thu, 12 Sep 2019 11:30:37 GMT
x-cdn: Incapsula
etag: "1D5695D7F8B2C80"
content-type: image/jpeg
status: 200
x-iinfo: 6-11833760-11829433 2VNN RT(1592455875659 0) q(0 0 0 -1) r(4 4) U18
cache-control: max-age=86401, public
content-length: 28397
expires: Fri, 19 Jun 2020 04:51:16 GMT

GET
H2 200 teva-logo-180x64.png
www.tevapharma.es/globalassets/scs-branded-images/generic-images/ 6 KB
6 KB 1243ms
1240ms Image
image/png 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.tevapharma.es/globalassets/scs-branded-images/generic-images/teva-logo-180x64.png
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: /
Resource Hash: c5bd6708fff819a3537eb0b2e6adb692faf348e49bacf5a434671a786e3af3bc

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:16 GMT
last-modified: Wed, 31 Jul 2019 08:38:57 GMT
x-cdn: Incapsula
etag: "1D5477B6480A680"
content-type: image/png
status: 200
x-iinfo: 6-11833761-11833762 2VNN RT(1592455875660 0) q(0 0 0 -1) r(0 12) U18
cache-control: max-age=86400, public
content-length: 6148
expires: Fri, 19 Jun 2020 04:51:16 GMT

GET
H2 200 error-icon-3.jpg
www.tevapharma.es/globalassets/scs-branded-images/generic-images/ 14 KB
14 KB 539ms
537ms Image
image/jpeg 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.tevapharma.es/globalassets/scs-branded-images/generic-images/error-icon-3.jpg
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash: dc21df25905b072455e0bd22b2600d2ac155eba1d30777de5e3ab9e19b04678d

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:15 GMT
x-cdn: Incapsula
x-aspnet-version: 4.0.30319
x-powered-by: ASP.NET, ARR/3.0
status: 200
x-iinfo: 6-11833763-11833164 2NNN RT(1592455875662 0) q(0 4 4 -1) r(5 5) U18
content-length: 14584
request-context: appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified: Mon, 22 Jul 2019 09:06:34 GMT
server: Microsoft-IIS/10.0
etag: "1D5406CC26F0900"
content-type: image/jpeg
access-control-expose-headers: Request-Context
cache-control: public
accept-ranges: bytes
expires: Fri, 19 Jun 2020 04:51:16 GMT

GET
H2 200 facebook_icon_footer21.png
www.tevapharma.es/globalassets/scs-branded-images/social-media-icons/ 731 B
867 B 512ms
510ms Image
image/png 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.tevapharma.es/globalassets/scs-branded-images/social-media-icons/facebook_icon_footer21.png
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: /
Resource Hash: 59f6c97f688febbac5d51195e7d8327242d5d5098ebeffe132d245db3b913d41

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:15 GMT
last-modified: Sun, 30 Jun 2019 05:42:39 GMT
x-cdn: Incapsula
etag: "1D52F06A0B7B180"
content-type: image/png
status: 200
x-iinfo: 6-11833766-11833436 2VNN RT(1592455875665 0) q(0 4 4 -1) r(5 5) U18
cache-control: max-age=86401, public
content-length: 731
expires: Fri, 19 Jun 2020 04:51:16 GMT

GET
H2 200 linkedin_icon_footer.png
www.tevapharma.es/globalassets/scs-branded-images/social-media-icons/ 913 B
1 KB 622ms
620ms Image
image/png 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.tevapharma.es/globalassets/scs-branded-images/social-media-icons/linkedin_icon_footer.png
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: /
Resource Hash: ac143371c574744f9c2617034350493f0c9739225e9eaea44f6635007e735b6e

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:16 GMT
last-modified: Wed, 20 Feb 2019 15:51:38 GMT
x-cdn: Incapsula
etag: "1D4C93429F52100"
content-type: image/png
status: 200
x-iinfo: 6-11833769-11833436 2VNN RT(1592455875668 0) q(0 5 5 -1) r(6 6) U18
cache-control: max-age=86400, public
content-length: 913
expires: Fri, 19 Jun 2020 04:51:16 GMT

GET
H2 200 twitter_icon_footer21.png
www.tevapharma.es/globalassets/scs-branded-images/social-media-icons/ 1 KB
1 KB 882ms
881ms Image
image/png 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.tevapharma.es/globalassets/scs-branded-images/social-media-icons/twitter_icon_footer21.png
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: /
Resource Hash: ff0b25b4524c1aada5ea2fd86094415cc8fe7a03102521e38d7969867fed171d

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:16 GMT
last-modified: Sun, 30 Jun 2019 05:42:39 GMT
x-cdn: Incapsula
etag: "1D52F06A0B7B180"
content-type: image/png
status: 200
x-iinfo: 6-11833771-11828318 2VNN RT(1592455875672 0) q(0 5 5 -1) r(9 9) U18
cache-control: max-age=86400, public
content-length: 1071
expires: Fri, 19 Jun 2020 04:51:16 GMT

GET
H2 200 youtube_icon_footer.png
www.tevapharma.es/globalassets/scs-branded-images/social-media-icons/ 424 B
548 B 902ms
900ms Image
image/png 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.tevapharma.es/globalassets/scs-branded-images/social-media-icons/youtube_icon_footer.png
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: /
Resource Hash: e1752be4023ceee466048a791c44790bbbdecbdac52724acd8c38d8d4a054011

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:16 GMT
last-modified: Wed, 20 Feb 2019 15:55:31 GMT
x-cdn: Incapsula
etag: "1D4C934B4D61B80"
content-type: image/png
status: 200
x-iinfo: 6-11833772-11830442 2VNN RT(1592455875674 0) q(0 5 5 -1) r(9 9)
cache-control: max-age=86400, public
content-length: 424
expires: Fri, 19 Jun 2020 04:51:16 GMT

GET
H2 200 js Show response
www.tevapharma.es/sala-de-prensa/notas-de-prensa/DependencyHandler.axd/4e4f765685e46bb290d544f8d2fbcfe9/1/ 713 KB
187 KB 132ms
131ms Script
application/x-javascript 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to

Full URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/DependencyHandler.axd/4e4f765685e46bb290d544f8d2fbcfe9/1/js
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash: 3d9cc2969b5dc11c8a05e266de285467b1340db3362fea0519aacf12c68a6c1c

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:15 GMT
content-encoding: gzip
x-cdn: Incapsula
x-aspnet-version: 4.0.30319
x-powered-by: ASP.NET, ARR/3.0
status: 200
x-iinfo: 6-11833757-11833683 PNNN RT(1592455875639 0) q(0 0 0 -1) r(1 1) U18
content-length: 190835
request-context: appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified: Thu, 18 Jun 2020 04:51:15 GMT
server: Microsoft-IIS/10.0
etag: "ea73c2db6153be19964868eb16c12c0f"
vary: Accept-Encoding
content-type: application/x-javascript
access-control-expose-headers: Request-Context
cache-control: public, must-revalidate, proxy-revalidate, max-age=864000, s-maxage=864000
expires: Sun, 28 Jun 2020 04:51:15 GMT

GET
H2 200 _Incapsula_Resource Show response
www.tevapharma.es/ 117 KB
16 KB 46ms
44ms Script
application/javascript 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to

Full URL: https://www.tevapharma.es/_Incapsula_Resource?SWJIYLWA=719d34d31c8e3a6e6fffd425f7e032f3&ns=1&cb=1067357208
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: /
Resource Hash: a82c285fed319e994686575bb3845837bfc39899db2dc617d99612ded2f63d16

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status: 200
content-encoding: gzip
cache-control: no-cache, no-store
x-robots-tag: noindex
content-length: 16792
content-type: application/javascript

GET
H2 200 gtm.js Show response
www.googletagmanager.com/ 130 KB
37 KB 46ms
26ms Script
application/javascript 2a00:1450:4001:825::2008
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtm.js?id=GTM-TTZJZQD

Requested by

Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:825::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

62b8df3e1b987ef0eb6876f034d256549f260341777734d18b6485fe05b905e7

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:15 GMT
content-encoding: br
vary: Accept-Encoding
status: 200
alt-svc: h3-28=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 37862
x-xss-protection: 0
last-modified: Thu, 18 Jun 2020 03:00:00 GMT
server: Google Tag Manager
strict-transport-security: max-age=31536000; includeSubDomains
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
access-control-allow-headers: Cache-Control
expires: Thu, 18 Jun 2020 04:51:15 GMT

GET
DATA 200
OK truncated
/ 1 KB
0 Image
image/svg+xml

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: dfd3047ef2f045a574c2566f01a0f9105ad9223b0f2c4aa4856ad7892f8566ed

Request headers

Referer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type: image/svg+xml

GET
H2 200 TevaSansWeb-Regular.woff2
www.tevapharma.es/modules/TeVa.SCS/Client/Fonts/ 38 KB
39 KB 333ms
333ms Font
application/font-woff 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to

Full URL: https://www.tevapharma.es/modules/TeVa.SCS/Client/Fonts/TevaSansWeb-Regular.woff2
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash: 4abe5ef6fe2a7da29132dc2622b4177ada956400b436d38bb9b2bd914f60e7af

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/DependencyHandler.axd/e60934c81b33a244aaf066e442a45709/1/css
Origin: https://www.tevapharma.es

Response headers

date: Thu, 18 Jun 2020 04:51:15 GMT
content-encoding: gzip
etag: "37febc0df42d61:0"
last-modified: Mon, 15 Jun 2020 06:34:21 GMT
server: Microsoft-IIS/10.0
x-powered-by: ASP.NET, ARR/3.0
content-type: application/font-woff
status: 200
x-iinfo: 6-11833774-11833787 NNYY CT(0 0 0) RT(1592455875688 0) q(0 2 2 -1) r(3 3) U18
access-control-expose-headers: Request-Context
cache-control: max-age=86400
accept-ranges: bytes
x-cdn: Incapsula
request-context: appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081

GET
H2 200 hands_teaser_2019.jpg
www.tevapharma.es/globalassets/spain-branded-images/humanize-health-images/ 71 KB
71 KB 885ms
884ms Image
image/jpeg 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.tevapharma.es/globalassets/spain-branded-images/humanize-health-images/hands_teaser_2019.jpg
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: /
Resource Hash: 6716594aec89977c305cd8a3ceec5ee1e000d5931715d8b9a34ea44fa28137ba

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:16 GMT
last-modified: Thu, 19 Sep 2019 09:22:07 GMT
x-cdn: Incapsula
etag: "1D56ECBB4EAC980"
content-type: image/jpeg
status: 200
x-iinfo: 6-11833775-11828609 2VNN RT(1592455875689 0) q(0 5 5 -1) r(9 9) U18
cache-control: max-age=86400, public
content-length: 72274
expires: Fri, 19 Jun 2020 04:51:16 GMT

GET
H2 200 news--media_316x316_4.jpg
www.tevapharma.es/globalassets/scs-branded-images/small-teaser-images/ 16 KB
16 KB 712ms
711ms Image
image/jpeg 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.tevapharma.es/globalassets/scs-branded-images/small-teaser-images/news--media_316x316_4.jpg
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash: 6b642ec6f194738072be5e25a76e82acf90e16d409af34dcab577e7c72e5dd23

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:15 GMT
x-cdn: Incapsula
x-aspnet-version: 4.0.30319
x-powered-by: ASP.NET, ARR/3.0
status: 200
x-iinfo: 6-11833776-11833436 2NNN RT(1592455875691 0) q(0 6 6 -1) r(7 7) U18
content-length: 16236
request-context: appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified: Thu, 28 Jun 2018 10:50:38 GMT
server: Microsoft-IIS/10.0
etag: "1D40ECDD9751300"
content-type: image/jpeg
access-control-expose-headers: Request-Context
cache-control: public
accept-ranges: bytes
expires: Fri, 19 Jun 2020 04:51:16 GMT

GET
H2 200 our-products_316x316_2.jpg
www.tevapharma.es/globalassets/scs-branded-images/small-teaser-images/ 12 KB
12 KB 991ms
990ms Image
image/jpeg 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.tevapharma.es/globalassets/scs-branded-images/small-teaser-images/our-products_316x316_2.jpg
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash: d2a773b94a0c93859b3b9b84c1650b02c58a398b8f3ba5746261bdc83b1c135e

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:16 GMT
x-cdn: Incapsula
x-aspnet-version: 4.0.30319
x-powered-by: ASP.NET, ARR/3.0
status: 200
x-iinfo: 6-11833777-11828615 2NNN RT(1592455875694 0) q(0 7 7 -1) r(10 10) U18
content-length: 12248
request-context: appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified: Thu, 28 Jun 2018 10:56:33 GMT
server: Microsoft-IIS/10.0
etag: "1D40ECEAD0DC680"
content-type: image/jpeg
access-control-expose-headers: Request-Context
cache-control: public
accept-ranges: bytes
expires: Fri, 19 Jun 2020 04:51:16 GMT

GET
H2 200 our-impact_local-policies-teaser-316x316.jpg
www.tevapharma.es/globalassets/scs-branded-images/small-teaser-images/ 98 KB
99 KB 977ms
976ms Image
image/jpeg 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.tevapharma.es/globalassets/scs-branded-images/small-teaser-images/our-impact_local-policies-teaser-316x316.jpg
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash: 3bf0973b7ff5b7829b6886eaae2db3a913da7c3f9517a17e50e762d76b38d6f5

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:16 GMT
x-cdn: Incapsula
x-aspnet-version: 4.0.30319
x-powered-by: ASP.NET, ARR/3.0
status: 200
x-iinfo: 6-11833778-11833436 2NNN RT(1592455875696 0) q(0 9 9 -1) r(10 10) U18
content-length: 100130
request-context: appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081
last-modified: Fri, 29 Jun 2018 21:09:12 GMT
server: Microsoft-IIS/10.0
etag: "1D40FED6D89CC00"
content-type: image/jpeg
access-control-expose-headers: Request-Context
cache-control: public
accept-ranges: bytes
expires: Fri, 19 Jun 2020 04:51:16 GMT

GET
H2 200 TevaSansWeb-Bold.woff2
www.tevapharma.es/modules/TeVa.SCS/Client/Fonts/ 40 KB
40 KB 358ms
358ms Font
application/font-woff 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to

Full URL: https://www.tevapharma.es/modules/TeVa.SCS/Client/Fonts/TevaSansWeb-Bold.woff2
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash: 90450f83b1809d0de69542722fc84150585a6eca8c92b45777c741624d6affb8

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/DependencyHandler.axd/e60934c81b33a244aaf066e442a45709/1/css
Origin: https://www.tevapharma.es

Response headers

date: Thu, 18 Jun 2020 04:51:15 GMT
content-encoding: gzip
etag: "bfb6b90df42d61:0"
last-modified: Mon, 15 Jun 2020 06:34:21 GMT
server: Microsoft-IIS/10.0
x-powered-by: ASP.NET, ARR/3.0
content-type: application/font-woff
status: 200
x-iinfo: 6-11833779-11833683 PNYN RT(1592455875698 0) q(0 3 3 -1) r(4 4) U18
access-control-expose-headers: Request-Context
cache-control: max-age=86400
accept-ranges: bytes
x-cdn: Incapsula
request-context: appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081

GET
H2 200 ai.0.js Show response
az416426.vo.msecnd.net/scripts/a/ 94 KB
22 KB 28ms
7ms Script
application/x-javascript 2606:2800:233:1cb7:261b:1f9c:2074:3c
EDGECAST

General

Check archive.org

Show headers Download Go to

Full URL: https://az416426.vo.msecnd.net/scripts/a/ai.0.js
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2606:2800:233:1cb7:261b:1f9c:2074:3c , United States, ASN15133 (EDGECAST, US),
Reverse DNS
Software: ECAcc (frc/8FA5) /
Resource Hash: 5201c813c37a4168cc5c20c701d4391fd0a55625f97eb9f263a74fb52b52fd0e

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Thu, 18 Jun 2020 04:51:15 GMT
content-encoding: gzip
content-md5: HdY95yzx9wIyQkVEGES+Ew==
age: 592
x-cache: HIT
status: 200
content-length: 22495
x-ms-lease-status: unlocked
last-modified: Tue, 04 Feb 2020 19:23:51 GMT
server: ECAcc (frc/8FA5)
etag: 0x8D7A9A7C460F06C
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: *
x-ms-request-id: defc4c64-a01e-00ba-222a-4504ed000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Length,Date,Transfer-Encoding
cache-control: public, max-age=1800
x-ms-version: 2009-09-19
expires: Thu, 18 Jun 2020 05:21:15 GMT

GET
H2 200 analytics.js Show response
www.google-analytics.com/ 45 KB
18 KB 61ms
8ms Script
text/javascript 2a00:1450:4001:809::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google-analytics.com/analytics.js

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-TTZJZQD

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:809::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

fd361b57998c76f86335afa28b8a62527d88a8200fb5c428d6f0fff73383e955

Security Headers

Name	Value
Strict-Transport-Security	max-age=10886400; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security: max-age=10886400; includeSubDomains; preload
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Thu, 04 Jun 2020 23:38:14 GMT
server: Golfe2
age: 697
date: Thu, 18 Jun 2020 04:39:38 GMT
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: public, max-age=7200
alt-svc: h3-28=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 18469
expires: Thu, 18 Jun 2020 06:39:38 GMT

GET
H2 200 collect
www.google-analytics.com/r/ 35 B
196 B 14ms
13ms Image
image/gif 2a00:1450:4001:809::200e
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google-analytics.com/r/collect?v=1&_v=j83&a=219304122&t=pageview&_s=1&dl=https%3A%2F%2Fwww.tevapharma.es%2Fsala-de-prensa%2Fnotas-de-prensa%2F309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple&dp=%2Fsala-de-prensa%2Fnotas-de-prensa%2F309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple&ul=ES&de=UTF-8&dt=error%20404%20page&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=YEBAAEAB~&jid=1801130399&gjid=1721562369&cid=1826297318.1592455876&tid=UA-113991057-2&_gid=1019996072.1592455876&_r=1&gtm=2wg6a0TTZJZQD&cg1=error%20404%20page&cg4=other&z=313092050

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:809::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Thu, 18 Jun 2020 04:51:15 GMT
x-content-type-options: nosniff
last-modified: Sun, 17 May 1998 03:00:00 GMT
server: Golfe2
status: 200
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
alt-svc: h3-28=":443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 35
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 left-arrow.svg
www.tevapharma.es/modules/TeVa.SCS/Client/Images/ 753 B
499 B 117ms
117ms Image
image/svg+xml 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.tevapharma.es/modules/TeVa.SCS/Client/Images/left-arrow.svg
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/DependencyHandler.axd/4e4f765685e46bb290d544f8d2fbcfe9/1/js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash: b4498c2184492e35dc0f4975b425535fb10228397b27c976e30e1785d5d9b1af

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/DependencyHandler.axd/e60934c81b33a244aaf066e442a45709/1/css
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:15 GMT
content-encoding: gzip
etag: "2f81c20df42d61:0"
last-modified: Mon, 15 Jun 2020 06:34:21 GMT
server: Microsoft-IIS/10.0
x-powered-by: ASP.NET, ARR/3.0
content-type: image/svg+xml
status: 200
x-iinfo: 6-11833795-11833683 PNYN RT(1592455876059 0) q(0 0 0 -1) r(1 1) U18
access-control-expose-headers: Request-Context
cache-control: max-age=86400
accept-ranges: bytes
x-cdn: Incapsula
request-context: appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081

GET
H2 200 right-arrow.svg
www.tevapharma.es/modules/TeVa.SCS/Client/Images/ 751 B
491 B 127ms
126ms Image
image/svg+xml 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.tevapharma.es/modules/TeVa.SCS/Client/Images/right-arrow.svg
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/DependencyHandler.axd/4e4f765685e46bb290d544f8d2fbcfe9/1/js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: Microsoft-IIS/10.0 / ASP.NET, ARR/3.0
Resource Hash: 428f85cde68a9071765a9c1a9b6bea9256e853d0a25c1b15940b8a5cbc404e88

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/DependencyHandler.axd/e60934c81b33a244aaf066e442a45709/1/css
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 18 Jun 2020 04:51:15 GMT
content-encoding: gzip
etag: "cab9c60df42d61:0"
last-modified: Mon, 15 Jun 2020 06:34:21 GMT
server: Microsoft-IIS/10.0
x-powered-by: ASP.NET, ARR/3.0
content-type: image/svg+xml
status: 200
x-iinfo: 6-11833796-11833787 PNYy RT(1592455876062 0) q(0 0 0 -1) r(1 1) U18
access-control-expose-headers: Request-Context
cache-control: max-age=86400
accept-ranges: bytes
x-cdn: Incapsula
request-context: appId=cid-v1:f2cd0fee-8599-43de-a63a-a181908a4081

GET
H2 200 _Incapsula_Resource
www.tevapharma.es/ 1 B
35 B 15ms
15ms Image
text/plain 45.60.34.221
INCAPSULA

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.tevapharma.es/_Incapsula_Resource?SWKMTFSR=1&e=0.7439793702464348
Requested by: Host: www.tevapharma.es
URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 45.60.34.221 , United States, ASN19551 (INCAPSULA, US),
Reverse DNS
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status: 200
cache-control: no-cache, no-store
x-robots-tag: noindex
content-length: 1
content-type: text/plain

POST
H/1.1 200
OK track Show response
dc.services.visualstudio.com/v2/ 96 B
519 B 901ms
901ms XHR
application/json 13.69.65.22
MICROSOFT-CORP-MS...

General

Check archive.org

Show headers Download Go to

Full URL

https://dc.services.visualstudio.com/v2/track

Requested by

Host: az416426.vo.msecnd.net
URL: https://az416426.vo.msecnd.net/scripts/a/ai.0.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

13.69.65.22 Amsterdam, Netherlands, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),

Reverse DNS

Software

Resource Hash

115112b8faf25ee448a345294401008cf38ef1560cb0220f235c0ccbf5f5d873

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/309-teva-lanza-en-espana-copaxone-acetato-de-glatiramero-40-mg-ml-tres-veces-por-semana-para-el-tratamiento-de-las-formas-recurrentes-de-esclerosis-multiple
Sdk-Context: appId
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-type: application/json

Response headers

x-ms-session-id: FF3DF154-003E-40E0-A39C-EA4B15DC657D
Strict-Transport-Security: max-age=31536000
X-Content-Type-Options: nosniff
Date: Thu, 18 Jun 2020 04:51:17 GMT
Access-Control-Max-Age: 3600
Content-Type: application/json; charset=utf-8
Access-Control-Allow-Origin: *
Access-Control-Allow-Headers: Origin, X-Requested-With, Content-Name, Content-Type, Accept, Sdk-Context
Content-Length: 96

Verdicts & Comments Add Verdict or Comment

57 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

11 Cookies

Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.

Domain/Path	Expires	Name / Value
.tevapharma.es/	1970-01-19 10:22:22	Name: _gid Value: GA1.2.1019996072.1592455876
www.tevapharma.es/	1970-01-19 10:20:55	Name: ___utmvc Value: Jrd0VBZuO6IrbuA0oOEtBNv+3yuePE1JVEO8dWc7PdIzEjMPNC2Uz49lku2aI3fVCMPT2V3mYqcFQnpmKFA2ROqkxywoMGLIIhyjKy/vOU9CLU2TdJYuFPQBWVtA+uBwjPBAl4YDEiDkg4wVuY0MftZoDhA9rNO5kDj8qaEiLXYvOFEdm3Uqgiwt1JeThmhCrU1hYRJhSVmlycoD58OOSC4r1nshOPG6RiEN0PDwd8h6LIYfAB3+eWFpnxg8zLXh29CYI6Os4NMryUMwqZfBixqw1m7L8VC68dx9+JgH8dUljfWGQo0WNRgnygVG3XKygDuK7Al5L1pdISNzdAtM0Hgvg67wQrit9cu0029+opx+jgBZ4/qhxpPAkv4U7v0G6pCU6KXtPzRDvafaq+uZlJOlE1eqCdp7iWJf6vSbxNqBYBnhERjlm3QpQwO+T9m3mGx3GXh2CBntQPlv+MfgFQ4+CDNsX04+uZee2IFNbJSG52/NxRlDcZgLMuKLNczz44BpRyFKV7TlQoGRNxRCjGA2OKxM6VfvPSxk7kukIBdL3sviqQ3g3Jddwz3Y37xK4s+AgYTwGFrGt1Gre4orkFWw7rkLPQm7xyeFA5F3lZ9m2GGPuc3u4MYw41CAfGS4Cv8aI7LBfEU0TFXYQ231y4RAKGLG1WtQu+vqnyXh2OlGErmD4pOD3Nydf5k6lbCDuE9cUn2duLD9oy8vJeCcmfP/PK1tXnEzrkJVPMaRPD0u7UJk6XXhvPGGGTK3c4yCBa1bUE4whn4H5Yqj5RJI0YPel+ocbBur0f77x2OJXkNHO+RNr8XkTTwR+5dQ+Nwc34/XFExMoAU9Jeo9ihkaFXfZ5mTi6maRB1pFP7tmjx9Tw91jM6Obc0byCO5uc9qXxYwhMeVJfoufE8p+kXnbTyEu+sXntCMJ7Fq/TOsq23GhrhIeLK/WoTqVBB8sMFRGrFeZwBP/PCDOh1uZ+SdEb3WbHNcMzS+5+QUQWgeMmB3nQRdy+9H8VNdSe417pWZhdG+3wVCavZuYpGFBGfuOgO6rCY7AnjYXhf3IhLpvZ/ft648zvx/cPPSQTY/JvbL1UstXz38/CWITsjWac9VdN+fm54+qZORFc06cW1GidYtgKILx09Dm6WyVRg/kXlrtQO3N6cA+CpqtOA8dDXsU8GKqr3QiQQZBh4teksK9mzyElhi1hsch1kwfFcG0TU6NwpYyTas3fKkZMXEO+CtgYb9JZ7EfMnfOgwZYSYXf/329LjqB4HJlAR9RN8pfTq6MuD39uO67G5dRWJB9hRu66kCh/mKvMUUWN+FryWIeZg4IT7xH4fcxX5CAmaO/B6jdxG4mvPLVZbn9sm1YKAlpGQ75ueQLaHYS12Y37fTG6YwJwyVHiMK+mwsW4APbbWg+M2QeinexP8fqpE/bEVsDI+BunfwTzH9s6iys/ZdwDmbWkb2xzbe9xHQGd01j4QG3Hf7wmDNsSYj6Xu9yWC3wIfqHQLd9Czk/NNhMBs9nwcISnRJMrMdzigQjQntbNWFaVTe5gAgwQQraeSMGnYs7IeutN966qeIAcCz4dcMPhkmhng3u8HnxtGW4/C8YsgCTy5JTje/UMUlFGsrYwx+RdMqTViSSUJu1wVwuJCxkaWdlc3Q9MTE0MjIzLHM9N2Q3YjhlYWE3MzZiN2VhMDg5NzU4MThhYTE2MDY0OWZhOTY4ODY5YjY1Njg2ODk5NjE3Mjk1NjQ3MzgxODM2OWE4ODc2OTZhNzk3MjcxNmY=
www.tevapharma.es/	1970-01-19 19:06:31	Name: ai_user Value: ymlZ3\|2020-06-18T04:51:15.911Z
.tevapharma.es/	1970-01-19 12:30:31	Name: _gcl_au Value: 1.1.1498416568.1592455876
.tevapharma.es/	1970-01-19 10:20:55	Name: _gat_UA-113991057-2 Value: 1
.tevapharma.es/	1969-12-31 23:59:59	Name: incap_ses_86_2161282 Value: KtXES4HlUHr6b8zlx4gxAcPy6l4AAAAAw0tZ+ecXrFByWtBuj2+ywQ==
.tevapharma.es/	1970-01-19 10:20:57	Name: myt_storevisit Value:
.tevapharma.es/	1970-01-19 19:05:12	Name: visid_incap_2161282 Value: FQMdc4PASB21A8qA74Pi28Ly6l4AAAAAQUIPAAAAAADT1xxG2VJLH5eqoWUwuNRn
.www.tevapharma.es/	1969-12-31 23:59:59	Name: ARRAffinity Value: 223242edffad9634629293fff1625d9fabbc117a1d9986a90aa14acc0ef3b705
.tevapharma.es/	1970-01-20 03:52:07	Name: _ga Value: GA1.2.1826297318.1592455876
www.tevapharma.es/	1969-12-31 23:59:59	Name: ASP.NET_SessionId Value: ptwdkpnttav2ezesnmabxbsw

1 Console Messages

A page may trigger messages to the console to be logged. These are often error messages about being unable to load a resource or execute a piece of JavaScript. Sometimes they also provide insight into the technology behind a website.

Source	Level	URL Text
console-api	log	URL: https://www.tevapharma.es/sala-de-prensa/notas-de-prensa/DependencyHandler.axd/4e4f765685e46bb290d544f8d2fbcfe9/1/js(Line 1290) Message: 1600

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

az416426.vo.msecnd.net
dc.services.visualstudio.com
www.google-analytics.com
www.googletagmanager.com
www.tevapharma.es
13.69.65.22
2606:2800:233:1cb7:261b:1f9c:2074:3c
2a00:1450:4001:809::200e
2a00:1450:4001:825::2008
45.60.34.221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www.tevapharma.es Open in urlscan Pro 45.60.34.221 Public Scan

Summary

urlscan.io Verdict: No classification

Domain & IP information

Screenshot Live screenshot Full Image

Page URL History Show full URLs

Detected technologies

Page Statistics

28 Requests

100 %HTTPS

60 %IPv6

5 Domains

5 Subdomains

6 IPs

3 Countries

732 kBTransfer

1916 kBSize

11 Cookies

8 Outgoing links

Page URL History

Redirected requests

28 HTTP transactions Everything HTML Script AJAX CSS Image Expand all 1 data transactions

Request headers

Response headers

Redirect headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

www.tevapharma.es Open in urlscan Pro
45.60.34.221 Public Scan

Screenshot
Live screenshot

Full Image

28
Requests

100 %
HTTPS

60 %
IPv6

5
Domains

5
Subdomains

6
IPs

3
Countries

732 kB
Transfer

1916 kB
Size

11
Cookies

28 HTTP transactions
1 data transactions